CANCER GENETICS, INC 4
4 · CANCER GENETICS, INC · Filed Feb 24, 2017
Insider Transaction Report
Form 4
SHARMA PANNA
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2017-02-22+200,000→ 200,000 totalExercise: $2.50Exp: 2027-02-22→ Common Stock, par value $0.0001 per share (200,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest in 48 equal monthly installments commencing on the date of grant until fully vested, provided that the reporting person remains a service provider to Cancer Genetics, Inc. through each applicable vesting period.